Director at AstraZeneca
Min is a Director and Fellow at Astrazeneca. He has over 15 years of pharmaceutical product development experience. Prior to AstraZeneca, Min worked at Johnson&Johnson, BD and Eli Lilly and on projects from concept phase through commercialization. His experience spans formulation development, device engineering, process engineering and packaging development. Currently, Min is focusing on parenteral product development, including new modalities, such as cell and gene therapy.
Min is an inventor or author of more than 100 issued patents and patent applications and peer-reviewed publications. Min received his Ph.D. in Materials Science and his MBA from United States. He completed his post-doctoral fellowship at Emory School of Medicine. His MS degrees are in Biotechnology and Computer Science. He is also a certified Six Sigma Black Belt from American Society for Quality (ASQ).
Title: Innovations in drug delivery and combination devices
- Emerging need for drug delivery systems to enable Cell & Gene therapy and other new modalities
- The current challenges with wearable devices for delivering high-volume drug products
- How can combination products enable modern clinical trials and personalized medicines